Loading...
Loading...
Available on 1 platform
Sign in to view source links and access this dataset
A systematic review of 96 studies on Managed Entry Agreements (MEAs) for pharmaceuticals, conducted by Hussain Abdulrahman Al-Omar and published in 2026. The review maps global evidence on MEA policies, system-level components, and implementation challenges, with a focus on European and North American health systems. It identifies key barriers such as inefficient regulatory frameworks and data infrastructure limitations.
The file is in DOCX format, requiring compatible software for viewing and analysis.